The elucidation of mechanisms of secondary brain injury (the molecular and neurochemical events that occur following a traumatic impact) that contribute to the morbidity and mortality of victims of severe traumatic brain injury (TBI)can be accomplished through basic science investigations using animal models of TBI. In the past five years, we have reported species-specific differences in the type and contribution of these mechanisms to secondary injury. As a Brain Trauma Research Center focused on improving clinical outcomes following a TBI,we continue to examine the role of these mechanisms to human secondary brain injury. The Clinical Core will enable the investigators of the five primary projects to correlate the findings of their basic science investigations in animal models with mechanisms and therapeutics targeted at decreasing secondary brain injury in human victims of TBI by: 1) providing serum, cerebrospinal fluid, and dialysate samples obtained from microdialysis of the extracellular fluid, and brain tissue from human victims of severe TBI, 2) providing standardized care to these patients during their acute care hospitalization, 3) determining the functional status, neuropsychological outcomes, and psychosocial adjustment of these patients at 3, 6, 12 and 24 months after injury and,4) maintaining a comprehensive database that contains acute physiological and clinical data, as well as long term functional status, neuropsychological outcome and psychosocial adjustment data.

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Program Projects (P01)
Project #
Application #
Study Section
National Institute of Neurological Disorders and Stroke Initial Review Group (NSD)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Pittsburgh
United States
Zip Code
Ikonomovic, Milos D; Mi, Zhiping; Abrahamson, Eric E (2017) Disordered APP metabolism and neurovasculature in trauma and aging: Combined risks for chronic neurodegenerative disorders. Ageing Res Rev 34:51-63
Jackson, Edwin K; Kotermanski, Shawn E; Menshikova, Elizabeth V et al. (2017) Adenosine production by brain cells. J Neurochem 141:676-693
Markos, Steven M; Failla, Michelle D; Ritter, Anne C et al. (2017) Genetic Variation in the Vesicular Monoamine Transporter: Preliminary Associations With Cognitive Outcomes After Severe Traumatic Brain Injury. J Head Trauma Rehabil 32:E24-E34
Kumar, Raj G; Rubin, Jonathan E; Berger, Rachel P et al. (2016) Principal components derived from CSF inflammatory profiles predict outcome in survivors after severe traumatic brain injury. Brain Behav Immun 53:183-193
Santarsieri, M; Kumar, R G; Kochanek, P M et al. (2015) Variable neuroendocrine-immune dysfunction in individuals with unfavorable outcome after severe traumatic brain injury. Brain Behav Immun 45:15-27
Janata, Andreas; Magnet, Ingrid A M; Uray, Thomas et al. (2014) Regional TNF? mapping in the brain reveals the striatum as a neuroinflammatory target after ventricular fibrillation cardiac arrest in rats. Resuscitation 85:694-701
Santarsieri, Martina; Niyonkuru, Christian; McCullough, Emily H et al. (2014) Cerebrospinal fluid cortisol and progesterone profiles and outcomes prognostication after severe traumatic brain injury. J Neurotrauma 31:699-712
Gandy, Sam; Ikonomovic, Milos D; Mitsis, Effie et al. (2014) Chronic traumatic encephalopathy: clinical-biomarker correlations and current concepts in pathogenesis. Mol Neurodegener 9:37
Alexander, Sheila A; Ren, Dianxu; Gunn, Scott R et al. (2014) Interleukin 6 and apolipoprotein E as predictors of acute brain dysfunction and survival in critical care patients. Am J Crit Care 23:49-57
Yan, Hong Q; Shin, Samuel S; Ma, Xiecheng et al. (2014) Differential effect of traumatic brain injury on the nuclear factor of activated T Cells C3 and C4 isoforms in the rat hippocampus. Brain Res 1548:63-72

Showing the most recent 10 out of 71 publications